Challenges of calculating cost-effectiveness thresholds.

Vallejo-Torres, Laura; Claxton, Karl; Edney, Laura C; Karnon, Jonathan; Lomas, James; Ochalek, Jessica; Paulden, Mike; Stadhouders, Niek; Vanness, David J

Vallejo-Torres, Laura; Claxton, Karl; Edney, Laura C; Karnon, Jonathan; Lomas, James; Ochalek, Jessica; Paulden, Mike; Stadhouders, Niek; Vanness, David J.

Afiliação

Vallejo-Torres L; University of Las Palmas de Gran Canaria, Canary Islands 35017, Spain. Electronic address: laura.vallejo@ulpgc.es.
Claxton K; University of York, York, UK.
Edney LC; Flinders University, Adelaide, SA, Australia.
Karnon J; Flinders University, Adelaide, SA, Australia.
Lomas J; University of York, York, UK.
Ochalek J; University of York, York, UK.
Paulden M; University of Alberta, Edmonton, AB, Canada.
Stadhouders N; Radboudumc IQ Healthcare, Nijmegen, Netherlands.
Vanness DJ; Pennsylvania State University Department of Health Policy and Administration, University Park, PA, USA.

Lancet Glob Health ; 11(10): e1508, 2023 10.

Article em En | MEDLINE | ID: mdl-37734789

Assuntos

Análise Custo-Benefício; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Lancet Glob Health Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google